Free Trial

Adaptive Biotechnologies (ADPT) SEC Filings & 10K Form

Adaptive Biotechnologies logo
$10.33 +0.09 (+0.88%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$10.25 -0.08 (-0.77%)
As of 08/1/2025 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Adaptive Biotechnologies SEC Filings

DateFilerForm TypeView
06/12/2025
3:51 PM
Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
12:40 PM
Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
Form SCHEDULE 13G/A
05/20/2025
6:46 PM
Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4/A
05/19/2025
6:59 PM
Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
9:34 AM
Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
Form SCHEDULE 13G
05/07/2025
10:42 AM
Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
Form SCHEDULE 13G/A
05/01/2025
4:38 PM
Adaptive Biotechnologies (Subject)
ROBINS HARLAN S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2025
3:15 PM
Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
3:13 PM
Adaptive Biotechnologies (Filer)
Form ARS
03/26/2025
5:48 PM
Adaptive Biotechnologies (Issuer)
ROBINS HARLAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:45 PM
Adaptive Biotechnologies (Subject)
ROBINS HARLAN S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
6:33 PM
Adaptive Biotechnologies (Issuer)
GRIFFIN MICHELLE RENEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
6:34 PM
Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
4:28 PM
Adaptive Biotechnologies (Subject)
GRIFFIN MICHELLE RENEE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
6:48 PM
Adaptive Biotechnologies (Issuer)
HERSHBERG ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:47 PM
Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
4:30 PM
Adaptive Biotechnologies (Subject)
HERSHBERG ROBERT (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
1:48 PM
Adaptive Biotechnologies (Subject)
NEUPERT PETER M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
6:14 PM
Adaptive Biotechnologies (Issuer)
GRIFFIN MICHELLE RENEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:15 PM
Adaptive Biotechnologies (Issuer)
HERSHBERG ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:16 PM
Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:16 PM
Adaptive Biotechnologies (Issuer)
OWEN KATEY EINTERZ (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:17 PM
Adaptive Biotechnologies (Issuer)
Pellini Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:17 PM
Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:18 PM
Adaptive Biotechnologies (Issuer)
ROBINS HARLAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:19 PM
Adaptive Biotechnologies (Issuer)
RUBINSTEIN JULIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:20 PM
Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:21 PM
Adaptive Biotechnologies (Issuer)
BENZENO SHARON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:22 PM
Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:22 PM
Adaptive Biotechnologies (Issuer)
LO FRANCIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:10 PM
Adaptive Biotechnologies (Subject)
GRIFFIN MICHELLE RENEE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:36 PM
Adaptive Biotechnologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2025
6:28 PM
Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:51 PM
Adaptive Biotechnologies (Subject)
ROBINS CHAD M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
7:21 PM
Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
10:23 AM
Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
Form SCHEDULE 13G/A
02/13/2025
4:11 PM
Adaptive Biotechnologies (Subject)
ROBINS CHAD M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
1:20 PM
Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SCHEDULE 13G/A
02/04/2025
5:13 AM
Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
Form SCHEDULE 13G/A
01/27/2025
3:00 PM
Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SCHEDULE 13G/A
11/19/2024
5:45 PM
Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump wipes out trillions overnight… (Ad)

Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.

Whether you take some of that wealth for yourself depends on if you watch this controversial exposé
11/13/2024
3:30 PM
Adaptive Biotechnologies (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G
11/13/2024
8:00 AM
Adaptive Biotechnologies (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SC 13G/A
11/12/2024
12:30 PM
Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
2:15 PM
Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G
11/07/2024
3:30 PM
Adaptive Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
5:07 AM
Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
Form SC 13G
11/04/2024
9:58 AM
Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/11/2024
3:14 PM
Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
10/10/2024
4:47 PM
Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:27 PM
Adaptive Biotechnologies (Issuer)
Taylor Stacy L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:18 PM
Adaptive Biotechnologies (Subject)
Taylor Stacy L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ADPT) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners